Gastroenteropancreatic neuroendocrine tumors: Role of surgery

被引:4
|
作者
Sauvanet, Alain [1 ]
机构
[1] Univ Paris Diderot, Hop Beaujon, AP HP, Dept HPB Surg,PMAD, 100 Blvd Gen Leclerc, F-92110 Clichy, France
关键词
Gastroenteropancreatic neuroendocrine tumors; Pancreatectomy; Pancreatic insufficiency; Observation; LYMPH-NODE INVOLVEMENT; ENDOCRINE TUMORS; SURGICAL-MANAGEMENT; PANCREATIC INSUFFICIENCY; SHORT-TERM; RESECTION; SURVIVAL; CM; LYMPHADENECTOMY; METAANALYSIS;
D O I
10.1016/j.ando.2019.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural history of gastroenteropancreatic (GEP) Neuroendocrine tumors (NETs) is better and better known so indications of surgery are presently selective. Surgical resection, but also endoscopic resection and observation, can be proposed for gastric NETs according to presentation, size and grade. For small bowel NETs, resection is frequently needed but should obtain the best compromise between radicality and postoperative functional disorders. Appendiceal NETs are frequently diagnosed by appendectomy for appendicitis, but some patients at high risk for lymph node metastasis and recurrence should be reoperated for radical resection. Rectal NETs are often diagnosed incidentally; the smallest (< 1 cm) can be resected endoscopically but the most aggressive need a oncological proctectomy. Pancreatic NETs represent a wide spectrum, ranging from fully benign tumors to very aggressive ones. lnsulinomas are mostly benign, responsible for incapacitating symptoms despite medical treatment, and should ideally be treated by parenchyma sparing resection, mainly enucleation. Conversely, symptoms of gastrinomas are efficiently treated medically but their resection needs an oncological approach. Nonfunctioning PNETs are more and more frequently and incidentally discovered. According to their size, presentation and patient's characteristics, they need a resection (oncological or parenchyma-sparing) or a close observation. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [21] Workup of Gastroenteropancreatic Neuroendocrine Tumors
    Dillon, Joseph S.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (02) : 165 - +
  • [22] An Update on Gastroenteropancreatic Neuroendocrine Tumors
    Cives, Mauro
    Strosberg, Jonathan
    ONCOLOGY-NEW YORK, 2014, 28 (09): : 749 - 758
  • [23] RADIOTHERAPY FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
    KIMMIG, BN
    MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 488 - 495
  • [24] Nutrition and Gastroenteropancreatic Neuroendocrine Tumors
    Go, Vay Liang W.
    Srihari, Priya
    Burns, Leigh Anne Kamerman
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (04) : 827 - +
  • [25] Treatment of gastroenteropancreatic neuroendocrine tumors
    U. Plöckinger
    B. Wiedenmann
    Virchows Archiv, 2007, 451 : 71 - 80
  • [26] The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
    Lawrence, Ben
    Gustafsson, Bjorn I.
    Chan, Anthony
    Svejda, Bernhard
    Kidd, Mark
    Modlin, Irvin M.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (01) : 1 - +
  • [27] Update on gastroenteropancreatic neuroendocrine tumors
    Andreasi, Valentina
    Partelli, Stefano
    Muffatti, Francesca
    Manzoni, Marco F.
    Capurso, Gabriele
    Falconi, Massimo
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (02) : 171 - 182
  • [28] Treatment of gastroenteropancreatic neuroendocrine tumors
    Ploeckinger, U.
    Wiedenmann, B.
    VIRCHOWS ARCHIV, 2007, 451 (Suppl 1) : S71 - S80
  • [29] Biomarkers of gastroenteropancreatic neuroendocrine tumors
    d'Herbomez, Michele
    Coppin, Lucie
    Bauters, Catherine
    Carnaille, Bruno
    Do Cao, Christine
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2016, 20 (07): : 174 - 177
  • [30] The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
    Cives, Mauro
    Strosberg, Jonathan
    DRUGS, 2015, 75 (08) : 847 - 858